🔓
Sign in as a Member to unlock the full view of HRES.277. · Full carveout list, all affected companies, party defectors, and 30-day trade predictions.
Become a Member$24.50/mo already a Member? Sign in →
HRES.277 · 119TH CONGRESS

Supporting the designation of May 2025 as "National Myositis Awareness Month".

Status
In Committee
Latest Action
2025-03-31
Sponsor
McCormick, Richard (R-Georgia)
Official Source
Investability
52/100
Stage
COMMITTEE
Related Bills
1
Full Text
2,430 chars
Alive
Yes

What This Bill Does · Plain English

Summary
Plain-English summary not yet available for this bill. Check back after our next analysis run.

Action Timeline

2025-03-31
Referred to the House Committee on Energy and Commerce.
2025-03-31
Submitted in House
2025-03-31
Submitted in House

Frequently Asked Questions

Did HRES.277 pass?
HRES.277 is still alive. Current stage: COMMITTEE. Pass likelihood: 52%.
Who sponsored HRES.277?
HRES.277 was sponsored by Richard McCormick (R-Georgia).

Full Bill Text

119 HRES 277 IH: Supporting the designation of May 2025 as “National Myositis Awareness Month”. U.S. House of Representatives 2025-03-31 text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IV 119th CONGRESS 1st Session H. RES. 277 IN THE HOUSE OF REPRESENTATIVES March 31, 2025 Mr. McCormick submitted the following resolution; which was referred to the Committee on Energy and Commerce RESOLUTION Supporting the designation of May 2025 as National Myositis Awareness Month . Whereas residents of the United States of America are among those affected by myositis and other rare diseases, with nearly 1 in 10 Americans having rare diseases; Whereas idiopathic inflammatory myopathies (collectively referred to as myositis) are rare, chronic, autoimmune muscle-wasting diseases that often feature debilitating muscle inflammation and other symptoms, such as pain, fatigue, and trouble swallowing, and can result in myositis-associated interstitial lung disease; Whereas more research is needed to identify the causes of and modes of treatments for the myositis group of diseases, which includes anti-MDA5 autoantibody-positive myositis, antisynthetase syndrome, dermatomyositis, juvenile dermatomyositis, immune-mediated necrotizing myopathy, inclusion body myositis, and polymyositis; Whereas myositis is difficult to diagnose which leads myositis patients to frequently experience delayed treatment and difficulty finding a health care provider with expertise in their condition; Whereas all who suffer with myositis experience reduced quality of life, particularly since no cure has been found and life expectancy is shortened, especially for those with inclusion body myositis, and women and people of color with all forms of myositis experience particularly pronounced health disparities; and Whereas public awareness and education campaigns on myositis detection and treatment are held during the month of May: Now, therefore, be it That the House of Representatives— (1) supports the designation of National Myositis Awareness Month ; (2) recognizes the importance of raising awareness about myositis and its impact on United States veterans and citizens; and (3) encourages all people in the United States to become more informed about myositis and to support the individuals and families who are affected by these conditions.
🔒 GovGreed Pro · Trading Intelligence on HRES.277 Get Access — $24.50/mo
Loading intelligence layer…
Bill text sourced from GovInfo.gov · public domain · last updated 2026-07-29. Plain-English summary, score breakdown, and trading-intelligence panels are GovGreed-original analysis derived from STOCK Act filings, SEC Form 4 disclosures, FEC contributions, and Senate LDA lobbying reports — all publicly filed federal records. GovGreed is not affiliated with the U.S. Government. Not financial advice. [live render]